3-Benzhydrylmorpholine
| 3-Benzhydrylmorpholine | |
|---|---|
 |
| Salts [] | |
|---|---|
| 3-Benzhydrylmorpholine hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 253.34 g/mol [1] |
| Predicted LogP | 2.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C17H19NO [1] |
| IUPAC name | 3-benzhydrylmorpholine [1] |
| SMILES | C1COCC(N1)C(C2=CC=CC=C2)C3=CC=CC=C3 [1] |
| InChI | InChI=1S/C17H19NO/c1-3-7-14(8-4-1)17(15-9-5-2-6-10-15)16-13-19-12-11-18-16/h1-10,16-18H,11-13H2 [1] |
| InChIKey | OVLYYUBKZWEOEQ-UHFFFAOYSA-N [1] |
3-Benzhydrylmorpholine (also known as 3-Benzhydrylmorpholine, Dtxsid60726714, Morpholine, 3-(diphenylmethyl)- or En300-1861388) is a
Chemistry
Salts []
3-Benzhydrylmorpholine is typically found in the form of its hydrochloride salt.
Stereochemistry []
3-Benzhydrylmorpholine is a racemic mixture of the enantiomers.
| Stereoisomerism |
|---|
| Stereoisomer enumberation with rdkit |
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 57466051, 3-(Diphenylmethyl)morpholine. Accessed May 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/57466051
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. 3-Benzhydrylmorpholine. UNII: ZMZ9TR3HUR. Global Substance Registration System. Accessed May 8, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/ZMZ9TR3HUR